874350-03-5

Upstream product

• 79271-56-0 triethylsilyl trifluoromethyl sulfonate 
• 773889-88-6 (1R,3S,5S)-1-(2-hydroxyethyl)-5-tri-isopropylsilyloxy-2-methylenecyclohexan-1,3-diol 
• 773889-91-1 (6R,7S,8S,10S)-7,8-epoxy-2,2,7-trimethyl-10-tri-isopropylsilyloxy-1,3-dioxaspiro[5.5]undecane 
• 874349-99-2 (1R,3S,5S)-1-[2-(tert-Butyl-dimethyl-silanyloxy)-ethyl]-2-methylene-5-triisopropylsilanyloxy-cyclohexane-1,3-diol 
• 874350-02-4 (1R,3S,5S)-1-(2-tert-butyldimethylsilyloxyethyl)-3-benzyloxy-5-triisopropylsilyloxy-2-methylencyclohexan-1-ol 

Downstream Products

• 874349-97-0 (1S,2R,4S,6S)-6-Benzyloxy-2-[2-(tert-butyl-dimethyl-silanyloxy)-ethyl]-1-(2-phenyl-[1,3]dithian-2-ylmethyl)-2-triethylsilanyloxy-4-triisopropylsilanyloxy-cyclohexanol 
• 874350-04-6 (1S,2R,4S,6S)-6-Benzyloxy-2-(2-hydroxy-ethyl)-1-(2-phenyl-[1,3]dithian-2-ylmethyl)-2-triethylsilanyloxy-4-triisopropylsilanyloxy-cyclohexanol 

Relevant academic research and scientific papers

Diastereoselective reactions at enantiomerically pure, sterically congested cyclohexanes as an entry to wailupemycins A and B: Total synthesis of (+)-wailupemycin B

Wailupemycin A (1) and B (2) are polyketide natural products with a highly substituted cyclohexanone core. Three different routes for the syntheses of these compounds were pursued, which commenced from either (R)-(-)-carvone (ent-5) or (S)-(+)-carvone (5)